Form 4 for CNMD CONMED Corp
Accepted 2025-05-21 00:00:00 ET · period of report 2025-05-20 · accession 0001127602-25-015194 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-21 | 2025-05-20 | CNMD | Workman John L | Dir | M - OptEx | $59.84 | +479 | 20.9K | +2% | +$28.7K |
| D | 2025-05-21 | 2025-05-20 | CNMD | Workman John L | Dir | M - OptEx | $0.00 | -479 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-20 | M | A | 479 | $59.84 | 20,891 | D | — | — | |
| 2 | Derivative | RSUs (Restricted Stock Units) | 2025-05-20 | M | D | 479 | $0.00 | 0 | D | $0.00 · 2025-06-03 to 2034-06-03 | 479 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. |